Home

Market Capitalization of Beta Drugs Ltd

Image

Beta Drugs Ltd

NSE: BETA

Market Cap

₹ 1640.51 crore

Last updated on: Mar 13, 2025

Key Highlights

  • The Market Cap of Beta Drugs Ltd is ₹ 1640 crore as of 13 Mar 25 .
  • The Latest Trading Price of Beta Drugs Ltd is ₹ 1706 as of 13 Mar 15:30 .
Image

Beta Drugs Ltd

NSE: BETA

Share Price

₹ 1706.4

43.70 (2.63%)

stock direction

Last updated on: Mar 13, 2025

Market Price of Beta Drugs Ltd

1M

1Y

3Y

5Y

Monitoring Beta Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
13 Mar 20251706.4
12 Mar 20251662.7
11 Mar 20251690
10 Mar 20251696.15
07 Mar 20251716.1
06 Mar 20251817.35
05 Mar 20251778
04 Mar 20251604.25
03 Mar 20251595
28 Feb 20251649.4

SWOT Analysis Of Beta Drugs Ltd

Strength

3

che

Weakness

2

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Beta Drugs Ltd

Asset Value vs Market Value of Beta Drugs Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of Market Cap

Key Valuation Metric of Beta Drugs Ltd

No data available

No data available

Historical P/E Ratio of Beta Drugs Ltd

No data available

* All values are in %

Historical Revenue of Beta Drugs Ltd

No data available

* All values are in crore

Historical EBITDA of Beta Drugs Ltd

No data available

* All values are in crore

Historical Net Profit of Beta Drugs Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

About Beta Drugs Ltd

  • Beta Drugs Limited was incorporated as a private limited company with the name 'Beta Drugs Private limited' at Himachal Pradesh on September 21, 2005.
  • Subsequently, the company was converted in to public limited company and the name of the company was changed to 'Beta Drugs Limited' on August 11, 2017 Beta Drugs is a part of Adley Group.
  • Adley Group was founded in the year 1985, by its promoter Vijay Batra, who has more than twenty five years of experience in manufacture of pharmaceutical products in India.
  • The Company is a pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers.
  • The Promoter Vijay Batra, took over the company from Kiran Goyal, Deepak Kumar Prince Bharti and Rohit Bansal in the year 2014.

Beta Drugs Ltd News Hub

Beta Drugs schedules AGM

Beta Drugs announced that the 19th Annual General Meeting (AGM) of the company will be held on 30 Se

Read more

02 Sept 24

Beta Drugs to conduct EGM

Beta Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 12

Read more

21 Oct 24

Beta Drugs to conduct board meeting

Beta Drugs will hold a meeting of the Board of Directors of the Company on 6 November 2024 Powered b

Read more

04 Nov 24

Beta Drugs schedules EGM

Beta Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 21

Read more

28 Nov 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Beta Drugs Ltd Market Cap

What is the market cap of Beta Drugs Ltd?

As of March 13, 2025, Beta Drugs Ltd has a market capitalization of ₹1640.51, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Beta Drugs Ltd's market capitalization?

Beta Drugs Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Beta Drugs Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Beta Drugs Ltd's market capitalization change?

Beta Drugs Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions